To Evaluate Effectiveness and Safety of GP0109 for Jawline Definition

NCT05110287 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2026-05-18

Study results available
· View outcomes & findings →

Summary

This study is designed to evaluate effectiveness and safety of GP0109 for Jawline definition

Conditions

  • Jawline Definition Deficiency

Interventions

DEVICE

GP0109

Treatment of the Jawline

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2023-03-15
Completion
2024-10-23

Countries

  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05110287 on ClinicalTrials.gov